» Articles » PMID: 37229448

Cellular Dynamics of Distinct Skeletal Cells and the Development of Osteosarcoma

Overview
Specialty Endocrinology
Date 2023 May 25
PMID 37229448
Authors
Affiliations
Soon will be listed here.
Abstract

Bone contributes to the maintenance of vital biological activities. At the cellular level, multiple types of skeletal cells, including skeletal stem and progenitor cells (SSPCs), osteoblasts, chondrocytes, marrow stromal cells, and adipocytes, orchestrate skeletal events such as development, aging, regeneration, and tumorigenesis. Osteosarcoma (OS) is a primary malignant tumor and the main form of bone cancer. Although it has been proposed that the cellular origins of OS are in osteogenesis-related skeletal lineage cells with cancer suppressor gene mutations, its origins have not yet been fully elucidated because of a poor understanding of whole skeletal cell diversity and dynamics. Over the past decade, the advent and development of single-cell RNA sequencing analyses and mouse lineage-tracing approaches have revealed the diversity of skeletal stem and its lineage cells. Skeletal stem cells (SSCs) in the bone marrow endoskeletal region have now been found to efficiently generate OS and to be robust cells of origin under deletion conditions. The identification of SSCs may lead to a more limited redefinition of bone marrow mesenchymal stem/stromal cells (BM-MSCs), and this population has been thought to contain cells from which OS originates. In this mini-review, we discuss the cellular diversity and dynamics of multiple skeletal cell types and the origin of OS in the native environment in mice. We also discuss future challenges in the study of skeletal cells and OS.

Citing Articles

Endosteal stem cells at the bone-blood interface: A double-edged sword for rapid bone formation: Bone marrow endosteal stem cells provide a robust source of bone-making osteoblasts both in normal and abnormal bone formation.

Matsushita Y, Liu J, Chu A, Ono W, Welch J, Ono N Bioessays. 2023; 46(3):e2300173.

PMID: 38161246 PMC: 11729589. DOI: 10.1002/bies.202300173.

References
1.
Del Mare S, Husanie H, Iancu O, Abu-Odeh M, Evangelou K, Lovat F . WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma. Cancer Res. 2016; 76(20):6107-6117. PMC: 5146760. DOI: 10.1158/0008-5472.CAN-16-0621. View

2.
Matsushita Y, Chu A, Tsutsumi-Arai C, Orikasa S, Nagata M, Wong S . The fate of early perichondrial cells in developing bones. Nat Commun. 2022; 13(1):7319. PMC: 9705540. DOI: 10.1038/s41467-022-34804-6. View

3.
Cho C, Xi J, Si Y, Park S, Hsu J, Kim M . Microscopic examination of spatial transcriptome using Seq-Scope. Cell. 2021; 184(13):3559-3572.e22. PMC: 8238917. DOI: 10.1016/j.cell.2021.05.010. View

4.
Lu L, Harutyunyan K, Jin W, Wu J, Yang T, Chen Y . RECQL4 Regulates p53 Function In Vivo During Skeletogenesis. J Bone Miner Res. 2015; 30(6):1077-89. DOI: 10.1002/jbmr.2436. View

5.
Donehower L, Harvey M, Slagle B, McArthur M, Montgomery Jr C, Butel J . Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356(6366):215-21. DOI: 10.1038/356215a0. View